Jerusalem Post: Fighting the Global Diabetes Epidemic with Israeli Innovation

Jerusalem-based Oramed Pharmaceuticals has developed an innovative oral insulin capsule transforming injectable treatments into oral therapies.

Oramed’s CEO Nadav Kidron speaks to The Jerusalem Post about the company’s technology .


You may also be interested

Join our mailing list

Skip to content